UNH UnitedHealth Group Incorporated Common Stock (DE)
O UnitedHealth Group Incorporated Common Stock (DE) Przegląd firmy z Wikipedii
UnitedHealth Group – amerykańskie przedsiębiorstwo z siedzibą w Minnetonka w stanie Minnesota, operujące w sektorze zarządzanej opieki zdrowotnej.
Czytaj więcej
UnitedHealth Group – amerykańskie przedsiębiorstwo z siedzibą w Minnetonka w stanie Minnesota, operujące w sektorze zarządzanej opieki zdrowotnej (managed health care).
Posiada wycenę rynkową szacowaną na 322 mld dolarów.
## Struktura
UnitedHealth Group świadczy swoje usługi w formie dwóch oddzielnych platorm:
UnitedHealthcare – usługi świadczeń zdrowotnych
UnitedHealthcare Employer & Individual – obsługuje duże przedsiębiorstwa, małe i średnie przedsiębiorstwa, osoby prywatne, a także członków i byłych członków armii.
UnitedHealthcare Medicare & Retirement – obsługuje osoby prywatne powyżej pięćdziesiątego roku życia.
UnitedHealthcare Community & State – obsługuje stanowe i społecznościowe programy świadczeniowe.
UnitedHealthcare Global – międzynarodowe usługi ubezpieczeniowe i medyczne.
Optum – usługi opieki zdrowotnej
OptumHealth – usługi zdrowotne dla osób indywidualnych
OptumInsight – usługi technologiczne, operacyjne i konsultingowe dla sektora opieki zdrowotnej, w tym dla szpitali, praktyki medycznej, komercyjnych planów zdrowotnych, agencji rządowych oraz innych organizacji.
OptumRX – usługi zarządzania świadczeniami farmaceutycznymi
Do grupy UnitedHealth grup należy brazylijskie przedsiębiorstwo Amil, operujące w sektorze świadczeń medycznych i dentystycznych oraz zarządzające ponad 30 szpitalami i 50 klinikami w Brazylii.
== Przypisy ==
Źródło: Wikipedia, CC BY-SA 4.0 · Zobacz w Wikipedii ↗
UNH Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
UNH Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 15 czerwca 2026 | $2,3200 |
| 9 marca 2026 | $2,2100 |
| 8 grudnia 2025 | $2,2100 |
| 15 września 2025 | $2,2100 |
| 16 czerwca 2025 | $2,2100 |
| 10 marca 2025 | $2,1000 |
| 9 grudnia 2024 | $2,1000 |
| 16 września 2024 | $2,1000 |
| 17 czerwca 2024 | $2,1000 |
| 8 marca 2024 | $1,8800 |
| 1 grudnia 2023 | $1,8800 |
| 8 września 2023 | $1,8800 |
| 15 czerwca 2023 | $1,8800 |
| 10 marca 2023 | $1,6500 |
| 2 grudnia 2022 | $1,6500 |
| 9 września 2022 | $1,6500 |
| 16 czerwca 2022 | $1,6500 |
| 11 marca 2022 | $1,4500 |
| 3 grudnia 2021 | $1,4500 |
| 10 września 2021 | $1,4500 |
UNH Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 8 23,5%
- Kup 19 55,9%
- Trzymaj 7 20,6%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
26 analityków · 2026-08-22Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $6.38 | $4.95 | 1.4% |
| 31 marca 2026 | $7.23 | $6.64 | 0.59% |
| 31 grudnia 2025 | $2.11 | $2.12 | -0.01% |
| 30 września 2025 | $2.92 | $2.82 | 0.10% |
| 30 czerwca 2025 | $4.08 | $4.53 | -0.45% |
| 31 marca 2025 | $7.20 | $7.36 | -0.16% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Cost of Revenue | $50.66B | $46.69B | $38.77B | $33.70B | $31.03B | $30.75B | $28.12B | $27.00B | $24.11B | $24.42B | $16.21B | $3.83B | |
| SG&A Expense | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.70B | $35.19B | $34.07B | $29.56B | $28.40B | $24.31B | $21.26B | |
| Operating Expenses | $428.60B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.90B | $185.95B | $171.91B | $146.09B | $120.20B | |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B | |
| Interest Expense | $4.00B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.70B | $1.40B | $1.19B | $1.07B | $790M | $618M | |
| Pretax Income | $14.70B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B | $14.02B | $11.86B | $10.23B | $9.66B | |
| Income Tax | $1.89B | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B | $3.74B | $3.56B | $3.20B | $4.79B | $4.36B | $4.04B | |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| EPS (Basic) | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 | $10.95 | $7.37 | $6.10 | $5.78 | |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 | |
| Shares (Basic) | 908,000,000 | 921,000,000 | 928,000,000 | 937,000,000 | 943,000,000 | 949,000,000 | 951,000,000 | 963,000,000 | 964,000,000 | 952,000,000 | 953,000,000 | 972,000,000 | |
| Shares (Diluted) | 911,000,000 | 929,000,000 | 938,000,000 | 950,000,000 | 956,000,000 | 961,000,000 | 966,000,000 | 983,000,000 | 985,000,000 | 968,000,000 | 967,000,000 | 986,000,000 | |
| EBITDA | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B | $10.87B | $11.98B | $10.43B | $10.92B | $7.50B | |
| Short-term Investments | $3.76B | $3.80B | $4.20B | $4.55B | $2.53B | $2.86B | $3.26B | $3.46B | $3.51B | $2.85B | $1.99B | $1.74B | |
| Receivables | $23.02B | $22.36B | $21.28B | $17.68B | $14.22B | $12.87B | $11.82B | $11.39B | $9.57B | $8.15B | $6.52B | $4.25B | |
| Inventory | $3.30B | $3.80B | $2.80B | $3.50B | $2.90B | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.75B | $8.21B | $6.08B | $6.62B | $5.32B | $4.46B | $3.85B | $3.09B | $2.66B | $1.85B | $2.41B | $1.05B | |
| Current Assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B | $38.69B | $37.08B | $33.88B | $31.64B | $23.56B | |
| PP&E (Net) | $10.76B | $10.55B | $11.45B | $10.13B | $8.97B | $8.63B | $8.70B | $8.46B | $7.01B | $5.90B | $4.86B | $4.42B | |
| Accum. Depreciation | $7.55B | $6.97B | $7.04B | $6.93B | $5.99B | $5.23B | $5.00B | $4.14B | $3.69B | $3.75B | $3.17B | $2.95B | |
| Goodwill | $110.50B | $106.73B | $103.73B | $93.35B | $75.80B | $71.34B | $65.66B | $58.91B | $54.56B | $47.58B | $44.45B | $32.94B | |
| Intangibles | $20.47B | $23.27B | $15.19B | $14.40B | $10.04B | $10.86B | $10.35B | $9.32B | $8.49B | $8.54B | $8.39B | $3.67B | |
| Other Non-current Assets | $23.01B | $19.59B | $17.30B | $15.03B | $12.53B | $11.51B | $9.33B | $4.33B | $3.58B | $3.04B | $3.12B | $2.97B | |
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.30B | |
| Accounts Payable | $38.03B | $34.34B | $31.96B | $27.71B | $24.64B | $22.50B | $19.00B | $16.70B | $15.18B | $13.36B | $11.99B | $9.25B | |
| Current Liabilities | $114.90B | $103.77B | $99.05B | $89.24B | $78.29B | $72.42B | $61.78B | $53.21B | $50.46B | $49.25B | $42.90B | $30.62B | |
| Deferred Tax | $2.42B | $3.62B | $3.02B | $2.77B | $3.27B | $3.37B | $2.99B | $2.47B | $2.18B | $2.76B | $3.59B | $2.06B | |
| Other Non-current Liabilities | $18.25B | $15.94B | $14.46B | $12.84B | $11.79B | $12.31B | $10.14B | $5.73B | $5.56B | $4.83B | $1.48B | $1.36B | |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B | $87.04B | $82.62B | $75.79B | $52.54B | |
| Long-term Debt | · | · | · | · | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $31.96B | $17.41B | |
| Total Debt | $72.32B | $72.36B | $58.26B | $54.51B | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $32.09B | $17.41B | |
| Common Stock | $9M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Paid-in Capital | $559M | $0 | $0 | · | $0 | $0 | $7M | $0 | $1.70B | $0 | $29M | $0 | |
| Retained Earnings | $95.60B | $96.04B | $95.77B | $86.16B | $77.13B | $69.30B | $61.18B | $55.85B | $48.73B | $40.95B | $37.12B | $33.84B | |
| AOCI | $-2.06B | $-3.39B | $-7.03B | $-8.39B | $-5.38B | $-3.81B | $-3.58B | $-4.16B | $-2.67B | $-2.68B | $-3.33B | $-1.39B | |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B | $68.33B | $60.44B | $54.32B | $49.83B | $38.18B | $33.73B | $32.45B | |
| Liabilities + Equity | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.38B | |
| Shares Outstanding | 906,000,000 | 915,000,000 | 924,000,000 | 934,000,000 | 941,000,000 | 946,000,000 | 948,000,000 | 960,000,000 | 969,000,000 | 952,000,000 | 953,000,000 | 954,000,000 |
Przepływy pieniężne 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.36B | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B | $2.72B | $2.43B | $2.25B | $2.06B | $1.69B | $1.48B | |
| Stock-based Comp | $971M | $1.02B | $1.06B | $925M | $800M | $679M | $697M | $638M | $597M | $485M | $406M | $364M | |
| Deferred Tax | $-1.75B | $-296M | $-245M | $-673M | $130M | $-8M | $230M | $42M | $-965M | $81M | $-73M | $-117M | |
| Amort. of Intangibles | $1.70B | $1.70B | $1.60B | $1.30B | $1.20B | $1.10B | $1.00B | $898M | $896M | $882M | $650M | $524M | |
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B | $13.60B | $9.79B | $9.74B | $8.05B | |
| CapEx | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B | $2.02B | $1.71B | $1.56B | $1.52B | |
| Investing Cash Flow | $-8.69B | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B | $-12.70B | $-12.38B | $-8.60B | $-9.36B | $-18.39B | $-2.53B | |
| Debt Issued | $2.97B | $17.81B | $6.39B | $14.82B | $6.93B | $4.86B | $5.44B | $6.93B | $5.29B | $3.97B | $11.98B | $2.00B | |
| Net Debt Issued | $-81M | $14.81B | $4.27B | $11.80B | $3.78B | $1.71B | $3.69B | $4.33B | $893M | $1.37B | $10.94B | $1.19B | |
| Stock Issued | $827M | $1.85B | $1.35B | $1.25B | $1.35B | $1.44B | $1.04B | $838M | $688M | $429M | $402M | $462M | |
| Stock Repurchased | $5.54B | $9.00B | $8.00B | $7.00B | $5.00B | $4.25B | $5.50B | $4.50B | $1.50B | $1.28B | $1.20B | $4.01B | |
| Net Stock Activity | $-4.72B | $-7.15B | $-6.65B | $-5.75B | $-3.65B | $-2.81B | $-4.46B | $-3.66B | $-812M | $-851M | $-798M | $-3.55B | |
| Dividends Paid | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B | |
| Financing Cash Flow | $-11.64B | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B | $-5.62B | $-4.37B | $-3.44B | $-1.01B | $12.24B | $-5.29B | |
| Net Change in Cash | $-947M | $-115M | $2.06B | $1.99B | $4.45B | $5.94B | $119M | $-1.11B | $1.55B | $-493M | $3.43B | $219M | |
| Taxes Paid | $3.71B | $4.62B | $6.08B | $5.22B | $3.97B | $4.93B | $3.54B | $3.26B | $4.00B | $4.73B | $4.40B | $4.02B | |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B | $8.18B | $6.53B | |
| Levered FCF | $12.59B | $17.74B | $23.10B | $21.76B | $18.57B | $18.86B | $15.04B | $12.56B | $10.66B | $7.45B | $7.73B | $6.17B |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| Net Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% | 3.7% | 4.3% | |
| Pretax Margin | 3.3% | 5.0% | 7.8% | 8.1% | 7.8% | 8.1% | 7.4% | 7.0% | 7.0% | 6.4% | 6.5% | 7.4% | |
| EBITDA Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| ROA | 4.0% | 4.8% | 8.6% | 8.8% | 8.4% | 8.3% | 8.5% | 8.2% | 8.1% | 6.0% | 5.9% | 6.7% | |
| ROE | 12.0% | 14.5% | 24.3% | 25.2% | 23.3% | 22.6% | 23.4% | 22.4% | 21.7% | 18.5% | 17.4% | 17.3% | |
| ROIC | 9.6% | 14.4% | 16.9% | 16.4% | 15.7% | 15.2% | 15.4% | 14.8% | 14.4% | 10.8% | 9.6% | 12.0% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
| Quick Ratio | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.9 | 1.0 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.5 | |
| Interest Coverage | 4.7 | 8.3 | 10.0 | 13.6 | 14.4 | 13.5 | 11.6 | 12.4 | 12.8 | 12.1 | 14.0 | 16.6 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | |
| Inventory Turnover | 14.3 | 14.1 | 12.3 | 10.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 19.7 | 18.3 | 19.1 | 20.3 | 21.2 | 20.8 | 20.9 | 21.6 | 22.7 | 25.2 | 29.2 | 35.7 |
Stopy Wzrostu 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 7.7% | 14.6% | 12.7% | 11.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.3% | 11.7% | 13.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -14.7% | -35.0% | 12.7% | 17.2% | 12.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -14.5% | -5.0% | 14.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -16.3% | -35.6% | 11.2% | 16.4% | 12.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.7% | -5.9% | 13.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -4.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Net Income TTM | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| Market Cap | $299.08B | $462.86B | $486.46B | $495.19B | $472.51B | $331.74B | $278.69B | $239.16B | $213.63B | $152.36B | $112.11B | $96.44B | |
| Enterprise Value | $343.28B | $506.11B | $515.09B | $521.79B | $494.61B | $355.43B | $305.13B | $261.39B | $229.83B | $172.05B | $131.29B | $104.61B | |
| P/E | 25.0 | 32.6 | 22.1 | 25.0 | 27.8 | 21.9 | 20.5 | 20.4 | 20.6 | 22.1 | 19.6 | 17.7 | |
| P/S | 0.7 | 1.2 | 1.3 | 1.5 | 1.6 | 1.3 | 1.2 | 1.1 | 1.1 | 0.8 | 0.7 | 0.7 | |
| P/B | 3.0 | 4.7 | 5.2 | 6.1 | 6.3 | 4.9 | 4.6 | 4.4 | 4.3 | 4.0 | 3.3 | 3.0 | |
| P / Cash Flow | 15.2 | 19.1 | 16.7 | 18.9 | 21.1 | 15.0 | 15.1 | 15.2 | 15.7 | 15.6 | 11.5 | 12.0 | |
| P / FCF | 18.6 | 22.4 | 18.9 | 21.2 | 23.8 | 16.5 | 17.0 | 17.5 | 18.5 | 18.8 | 13.7 | 14.8 | |
| EV / EBITDA | 18.1 | 15.7 | 15.9 | 18.4 | 20.6 | 15.9 | 15.5 | 15.1 | 15.1 | 13.3 | 11.9 | 10.2 | |
| EV / FCF | 21.4 | 24.4 | 20.1 | 22.3 | 24.9 | 17.7 | 18.6 | 19.1 | 19.9 | 21.3 | 16.0 | 16.0 | |
| EV / Revenue | 0.8 | 1.3 | 1.4 | 1.6 | 1.7 | 1.4 | 1.3 | 1.2 | 1.1 | 0.9 | 0.8 | 0.8 | |
| Dividend Yield | 2.6% | 1.6% | 1.4% | 1.2% | 1.1% | 1.4% | 1.4% | 1.4% | 1.3% | 1.5% | 1.6% | 1.4% | |
| Earnings Yield | 4.0% | 3.1% | 4.5% | 4.0% | 3.6% | 4.6% | 4.9% | 4.9% | 4.9% | 4.5% | 5.1% | 5.6% | |
| Payout Ratio | 65.7% | 52.3% | 30.2% | 29.8% | 30.6% | 29.8% | 28.4% | 27.7% | 26.3% | 32.2% | 30.7% | 24.2% | |
| Annual Payout | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B | $92.36B | $92.90B | $91.93B | $82.79B | $80.89B | |
| Cost of Revenue | $13.38B | $12.82B | $12.68B | $12.57B | $13.02B | $12.39B | $12.46B | $11.83B | $11.34B | $11.06B | $10.19B | $9.42B | $9.75B | $9.40B | $8.31B | $8.31B | |
| SG&A Expense | $14.27B | $15.39B | $17.00B | $15.22B | $13.78B | $13.59B | $12.49B | $13.28B | $13.16B | $14.08B | $13.34B | $13.86B | $13.81B | $13.62B | $13.01B | $11.66B | |
| Operating Expenses | $104.04B | $102.73B | $112.83B | $108.85B | $106.47B | $100.46B | $93.03B | $92.11B | $90.98B | $91.86B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | |
| Operating Income | $7.99B | $8.99B | $380M | $4.32B | $5.15B | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | |
| Interest Expense | $962M | $955M | $974M | $1.00B | $1.03B | $998M | $1.00B | $1.07B | $985M | $844M | $830M | $834M | $828M | $754M | $676M | $516M | |
| Pretax Income | $6.97B | $7.96B | $-720M | $3.23B | $4.08B | $8.11B | $6.79B | $7.61B | $5.67B | $1M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | |
| Income Tax | $1.30B | $1.48B | $-938M | $686M | $510M | $1.63B | $1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | |
| Net Income | $5.48B | $6.28B | $10M | $2.35B | $3.41B | $6.29B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | |
| EPS (Basic) | $6.06 | $6.92 | $0.03 | $2.59 | $3.76 | $6.90 | $6.03 | $6.56 | $4.58 | $-1.53 | $5.91 | $6.31 | $5.89 | $6.01 | $5.09 | $5.63 | |
| EPS (Diluted) | $6.04 | $6.90 | $0.05 | $2.59 | $3.74 | $6.85 | $5.99 | $6.51 | $4.54 | $-1.53 | $5.85 | $6.24 | $5.82 | $5.95 | $5.02 | $5.55 | |
| Shares (Basic) | 902,000,000 | 908,000,000 | -1,817,000,000 | 906,000,000 | 907,000,000 | 912,000,000 | -1,845,000,000 | 923,000,000 | 921,000,000 | 922,000,000 | -1,861,000,000 | 926,000,000 | 930,000,000 | 933,000,000 | -1,876,000,000 | 935,000,000 | |
| Shares (Diluted) | 906,000,000 | 910,000,000 | -1,825,000,000 | 908,000,000 | 910,000,000 | 918,000,000 | -1,851,000,000 | 930,000,000 | 928,000,000 | 922,000,000 | -1,881,000,000 | 936,000,000 | 940,000,000 | 943,000,000 | -1,902,000,000 | 948,000,000 | |
| EBITDA | $7.99B | $8.99B | · | $4.32B | $5.15B | $9.12B | · | $8.71B | $7.88B | $7.93B | · | $8.53B | $8.06B | $8.09B | · | $7.46B |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | · | $38.91B | $41.81B | $41.91B | · | $38.84B | |
| Short-term Investments | $2.88B | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B | $4.73B | $5.04B | $4.30B | · | $5.18B | $4.47B | $4.58B | · | $3.68B | |
| Receivables | $21.57B | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B | $20.02B | $23.11B | $27.20B | · | $20.67B | $17.95B | $22.41B | · | $17.05B | |
| Inventory | · | · | $3.30B | · | · | · | $3.80B | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.10B | $8.72B | $9.75B | $9.02B | $8.96B | $9.04B | $8.21B | $7.64B | $7.42B | $6.13B | · | $5.77B | $5.88B | $6.45B | · | $5.66B | |
| Current Assets | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B | $92.26B | $92.04B | $88.94B | · | $91.91B | $89.87B | $93.89B | · | $82.94B | |
| PP&E (Net) | $10.76B | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B | $10.14B | $9.80B | $10.43B | · | $11.07B | $10.93B | $10.64B | · | $9.47B | |
| Accum. Depreciation | · | · | $7.55B | · | · | · | $6.97B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $110.64B | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | |
| Intangibles | $19.75B | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B | $23.59B | $14.73B | $15.54B | · | $15.20B | $15.64B | $16.16B | · | $10.79B | |
| Other Non-current Assets | $24.00B | $23.46B | $23.01B | $22.98B | $21.30B | $20.39B | $19.59B | $18.65B | $17.94B | $17.70B | · | $16.71B | $16.07B | $15.69B | · | $14.41B | |
| Total Assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | |
| Accounts Payable | $39.74B | $38.63B | $38.03B | $36.03B | $34.33B | $33.57B | $34.34B | $33.08B | $30.89B | $30.74B | · | $31.16B | $29.52B | $29.86B | · | $27.23B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $7.30B | · | $2.60B | $4.40B | $8.20B | · | · | |
| Current Liabilities | $111.82B | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B | $101.56B | $104.67B | $104.43B | · | $114.18B | $112.98B | $116.48B | · | $100.94B | |
| Deferred Tax | $2.72B | $2.86B | $2.42B | $3.16B | $3.80B | $3.90B | $3.62B | $4.01B | $3.63B | $4.17B | · | $2.21B | $2.50B | $2.83B | · | $1.66B | |
| Other Non-current Liabilities | $19.73B | $18.90B | $18.25B | $18.37B | $15.71B | $15.96B | $15.94B | $15.17B | $14.79B | $14.84B | · | $13.62B | $13.26B | $13.08B | · | $12.11B | |
| Total Liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B | $186.82B | $187.29B | · | $188.08B | $188.01B | $193.06B | · | $160.14B | |
| Total Debt | $69.50B | $71.44B | · | $72.40B | $73.50B | $71.28B | · | $74.10B | $63.73B | $71.15B | · | $60.68B | $63.67B | $68.86B | · | $45.44B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $10M | |
| Paid-in Capital | $0 | $556M | $559M | $394M | · | · | $0 | $461M | $373M | · | · | · | · | · | · | · | |
| Retained Earnings | $100.96B | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | $96.04B | $96.52B | $92.40B | $90.12B | · | $93.17B | $89.99B | $88.85B | · | $83.72B | |
| AOCI | $-2.52B | $-2.56B | $-2.06B | $-2.21B | $-2.54B | $-2.90B | $-3.39B | $-2.45B | $-3.42B | $-3.44B | · | $-8.69B | $-7.65B | $-7.55B | · | $-9.09B | |
| Stockholders' Equity | $104.51B | $103.89B | $100.09B | $101.57B | $100.47B | $100.81B | $98.27B | $99.88B | $94.68B | $92.37B | $94.42B | $89.56B | $87.37B | $85.82B | $81.45B | $78.06B | |
| Liabilities + Equity | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | · | $282.06B | $280.16B | $283.68B | · | $243.06B | |
| Shares Outstanding | 905,000,000 | 908,000,000 | 906,000,000 | 906,000,000 | 905,000,000 | 910,000,000 | 915,000,000 | 923,000,000 | 921,000,000 | 920,000,000 | 924,000,000 | 925,000,000 | 927,000,000 | 932,000,000 | 934,000,000 | 935,000,000 |
Przepływy pieniężne 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.04B | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | $1.04B | $1.04B | $1.02B | $997M | $974M | $1.01B | $1.02B | $970M | $982M | $828M | |
| Stock-based Comp | $276M | $348M | $176M | $223M | $197M | $375M | $187M | $237M | $222M | $372M | $208M | $247M | $242M | $362M | $250M | $171M | |
| Deferred Tax | $-129M | $540M | $-733M | $-932M | $-151M | $64M | $-62M | $124M | $-331M | $-27M | $249M | $-12M | $-150M | $-332M | $-83M | $-575M | |
| Operating Cash Flow | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | |
| CapEx | $799M | $763M | $948M | $890M | $886M | $898M | $912M | $991M | $853M | $743M | $959M | $838M | $829M | $760M | $866M | $724M | |
| Investing Cash Flow | $-1.80B | $-2.45B | $-2.61B | $-4.56B | $-1.44B | $-74M | $-1.12B | $-5.65B | $-7.42B | $-6.34B | $-1.19B | $-2.64B | $-728M | $-11.02B | $-15.37B | $-847M | |
| Debt Issued | · | · | $0 | $0 | $2.97B | $0 | $0 | $11.89B | $0 | $5.92B | $0 | $0 | $-7M | $6.40B | $8.90B | $0 | |
| Net Debt Issued | · | $-1.50B | · | · | · | $0 | · | · | · | $5.17B | · | · | · | $5.03B | · | · | |
| Stock Issued | $128M | $231M | $24M | $222M | $221M | $360M | $235M | $867M | $258M | $486M | $314M | $411M | $284M | $344M | $169M | $328M | |
| Stock Repurchased | $1.65B | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B | $956M | $0 | $3.07B | $1.50B | $1.50B | $3.00B | $2.00B | $1.00B | $1.00B | |
| Net Stock Activity | · | $231M | · | · | · | $-2.64B | · | · | · | $-2.59B | · | · | · | $-1.66B | · | · | |
| Dividends Paid | $2.09B | $2.00B | $2.00B | $2.00B | $2.00B | $1.91B | $1.93B | $1.94B | $1.94B | $1.73B | $1.74B | $1.74B | $1.75B | $1.54B | $1.54B | $1.54B | |
| Financing Cash Flow | $-8.62B | $-2.99B | $-1.03B | $-2.77B | $-7.95B | $99M | $-8.34B | $-2.21B | $-1.20B | $8.23B | $-7.16B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | |
| Net Change in Cash | $584M | $3.64B | $-2.85B | $-1.39B | $-2.12B | $5.41B | $-7.09B | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100M | $18.55B | $-15.48B | $14.23B | |
| Free Cash Flow | · | $8.15B | · | · | · | $4.56B | · | · | · | $401M | · | · | · | $15.57B | · | · | |
| Levered FCF | · | $7.37B | · | · | · | $3.76B | · | · | · | $1.03T | · | · | · | $14.97B | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| Net Margin | 4.9% | 5.6% | · | 2.1% | 3.0% | 5.7% | · | 6.0% | 4.3% | -1.4% | · | 6.3% | 5.9% | 6.1% | · | 6.5% | |
| Pretax Margin | 6.2% | 7.1% | · | 2.9% | 3.7% | 7.4% | · | 7.5% | 5.7% | 0.00% | · | 8.3% | 7.8% | 8.0% | · | 8.6% | |
| EBITDA Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| ROA | 1.8% | 2.0% | · | 0.76% | 1.1% | 2.1% | · | 2.1% | 1.5% | -0.50% | · | 2.2% | 2.1% | 2.2% | · | 2.3% | |
| ROE | 5.3% | 6.1% | · | 2.3% | 3.5% | 6.5% | · | 6.4% | 4.6% | -1.6% | · | 7.0% | 6.7% | 6.9% | · | 7.0% | |
| ROIC | 3.7% | 4.2% | · | 1.9% | 2.6% | 4.2% | · | 4.1% | 3.9% | -5922.1% | · | 4.5% | 4.2% | 4.1% | · | 4.7% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | 8.3 | 9.4 | · | 4.3 | 5.0 | 9.1 | · | 8.1 | 8.0 | 9.4 | · | 10.2 | 9.7 | 10.7 | · | 14.5 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 4.9 | 4.2 | · | 5.3 | 4.7 | 4.0 | · | 5.0 | 4.8 | 4.0 | · | 4.9 | 5.1 | 4.5 | · | 5.2 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $448.53B | $446.07B | · | $435.17B | $420.87B | $409.05B | · | $391.83B | $383.92B | $376.99B | · | $358.09B | $346.06B | $333.31B | · | $313.71B | |
| Net Income TTM | $17.52B | $18.33B | · | $18.10B | $19.97B | $15.15B | · | $14.70B | $14.12B | $15.52B | · | $22.19B | $21.42B | $20.97B | · | $19.45B | |
| Market Cap | $376.15B | $245.70B | · | $312.84B | $282.33B | $476.61B | · | $539.66B | $469.03B | $455.12B | · | $466.38B | $445.55B | $440.45B | · | $472.21B | |
| Enterprise Value | $414.18B | $285.91B | · | $354.63B | $323.81B | $513.61B | · | $576.63B | $501.43B | $493.56B | · | $482.96B | $462.94B | $462.81B | · | $475.12B | |
| P/E | 21.6 | 13.5 | · | 17.5 | 14.4 | 32.0 | · | 37.1 | 33.8 | 30.0 | · | 21.4 | 21.2 | 21.4 | · | 24.7 | |
| P/S | 0.8 | 0.6 | · | 0.7 | 0.7 | 1.2 | · | 1.4 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.5 | |
| P/B | 3.6 | 2.4 | · | 3.1 | 2.8 | 4.7 | · | 5.4 | 5.0 | 4.9 | · | 5.2 | 5.1 | 5.1 | · | 6.0 | |
| P / Cash Flow | · | 27.6 | · | · | · | 87.4 | · | · | · | 397.8 | · | · | · | 27.0 | · | · | |
| P / FCF | · | 30.2 | · | · | · | 104.6 | · | · | · | 1135.0 | · | · | · | 28.3 | · | · | |
| EV / EBITDA | 51.8 | 31.8 | · | 82.2 | 62.9 | 56.3 | · | 66.2 | 63.7 | 62.2 | · | 56.6 | 57.5 | 57.2 | · | 63.7 | |
| EV / FCF | · | 35.1 | · | · | · | 112.7 | · | · | · | 1230.8 | · | · | · | 29.7 | · | · | |
| EV / Revenue | 0.9 | 0.6 | · | 0.8 | 0.8 | 1.3 | · | 1.5 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.4 | · | 1.5 | |
| Earnings Yield | 4.6% | 7.4% | · | 5.7% | 6.9% | 3.1% | · | 2.7% | 3.0% | 3.3% | · | 4.7% | 4.7% | 4.7% | · | 4.0% | |
| Payout Ratio | · | 31.9% | · | · | · | 30.4% | · | · | · | -122.7% | · | · | · | 27.4% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Przychody | $447.57B | — | — | $400.28B | — |
| Marża Operacyjna % | 4.2% | — | — | 8.1% | — |
| Zysk netto | $12.06B | — | — | $14.40B | — |
| Rozwodniony EPS | $13.23 | — | — | $15.51 | — |
Bilans
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.7 | — | — | 0.7 | — |
| Wskaźnik bieżący | 0.8 | — | — | 0.8 | — |
| Wskaźnik Szybkości | 0.4 | — | — | 0.5 | — |
Przepływy pieniężne
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $16.07B | — | — | $20.70B | — |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- Czy akcje UnitedHealth są nadal niedowartościowane?
- UnitedHealth Lost Nearly 1 Million Medicare Members. Here's Why Investors Aren't Worried
- UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results
- Czy UnitedHealth Group to dobra inwestycja po ostatnim raporcie wyników?
- JPMorgan Raises its Price Target on UnitedHealth Group (UNH)
- UnitedHealth Stock Jumps on Upgrade From Bank of America. UNH Is No Longer Just an Insurance Company.
- Codzienny Raport Dywidendowy: MDT,ACM,UNH,RICK,VRT
- Ten Ogromny Gigant Sektora Ochrony Zdrowia Cicho Staje Się Potęgą AI
- UnitedHealth Group (UNH) – Wśród 10 akcji o wysokiej jakości, które warto kupić według funduszy hedgingowych
- Akcje UnitedHealth (UNH) Spadają po Wyjściu Berkshire Hathaway, Podaje Reuters
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 3 750 emitentów · $243.6B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 507 (+257 vs poprzedni kw.) | 124 (-254 vs poprzedni kw.) | 1 283 (+66 vs poprzedni kw.) | 1 289 (-96 vs poprzedni kw.) | +25.6M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $27 207 979 474 | 82 420 949 | 11,17% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $24 651 649 136 | 59 311 525 | 10,12% | Akcje |
| STATE STREET CORP | $18 966 554 763 | 45 633 267 | 7,79% | Akcje |
| Capital World Investors | $12 422 776 956 | 29 887 932 | 5,10% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10 175 966 547 | 24 483 234 | 4,18% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $7 770 611 877 | 18 774 463 | 3,19% | Akcje |
| FMR LLC | $7 185 101 298 | 17 287 254 | 2,95% | Akcje |
| NORGES BANK | $5 293 868 088 | 12 736 973 | 2,17% | Akcje |
| Capital Research Global Investors | $4 378 631 657 | 10 534 177 | 1,80% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $4 210 086 678 | 10 129 410 | 1,73% | Akcje |
| Fisher Asset Management, LLC | $3 774 863 715 | 9 082 269 | 1,55% | Akcje |
| Dodge & Cox | $3 770 702 593 | 9 072 258 | 1,55% | Akcje |
| Capital International Investors | $3 237 872 783 | 7 789 028 | 1,33% | Akcje |
| JANE STREET GROUP, LLC | $3 165 978 399 | 7 617 300 | 1,30% | Opcja kupna |
| Sanders Capital, LLC | $2 451 649 249 | 5 898 634 | 1,01% | Akcje |
| EAGLE CAPITAL MANAGEMENT LLC | $2 399 442 912 | 5 773 026 | 0,99% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 119 167 278 | 5 098 687 | 0,87% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $2 075 268 358 | 7 669 420 | 0,85% | Akcje |
| MORGAN STANLEY | $2 055 731 816 | 4 946 062 | 0,84% | Akcje |
| JANE STREET GROUP, LLC | $2 055 124 098 | 4 944 600 | 0,84% | Opcja sprzedaży |
| DIMENSIONAL FUND ADVISORS LP | $1 717 292 161 | 4 131 778 | 0,71% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $1 526 781 892 | 3 673 416 | 0,63% | Akcje |
| AMERIPRISE FINANCIAL INC | $1 405 176 851 | 3 380 319 | 0,58% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1 251 138 985 | 3 010 223 | 0,51% | Akcje |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1 174 164 878 | 2 825 022 | 0,48% | Akcje |
| BlackRock, Inc. | $1 158 005 862 | 2 786 146 | 0,48% | Akcje |
| UBS Group AG | $1 092 471 817 | 2 628 472 | 0,45% | Opcja kupna |
| BANK OF AMERICA CORP /DE/ | $1 087 853 337 | 2 617 360 | 0,45% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1 065 664 884 | 2 563 973 | 0,44% | Akcje |
| Swiss National Bank | $1 064 029 841 | 2 560 041 | 0,44% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $1 055 107 927 | 2 538 575 | 0,43% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $971 757 071 | 2 338 034 | 0,40% | Akcje |
| BARCLAYS PLC | $897 842 266 | 2 160 196 | 0,37% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $874 984 816 | 2 105 201 | 0,36% | Akcje |
| Walleye Trading LLC | $861 060 671 | 2 071 700 | 0,35% | Opcja sprzedaży |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $860 919 095 | 2 071 359 | 0,35% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $847 773 811 | 2 039 732 | 0,35% | Akcje |
| Walleye Trading LLC | $845 183 605 | 2 033 500 | 0,35% | Opcja kupna |
| Vanguard Global Advisers, LLC | $819 257 021 | 1 971 121 | 0,34% | Akcje |
| National Pension Service | $818 929 089 | 1 970 332 | 0,34% | Akcje |
| WOLVERINE TRADING, LLC | $815 453 232 | 2 362 400 | 0,33% | Opcja kupna |
| ENVESTNET ASSET MANAGEMENT INC | $811 129 699 | 1 951 573 | 0,33% | Akcje |
| California Public Employees Retirement System | $799 750 674 | 1 924 189 | 0,33% | Akcje |
| Pentwater Capital Management LP | $777 228 100 | 1 870 000 | 0,32% | Opcja kupna |
| Legal & General Group Plc | $771 950 431 | 1 857 302 | 0,32% | Akcje |
| HSBC HOLDINGS PLC | $751 372 125 | 1 802 500 | 0,31% | Opcja sprzedaży |
| MILLENNIUM MANAGEMENT LLC | $672 345 116 | 1 617 653 | 0,28% | Akcje |
| GOLDMAN SACHS GROUP INC | $636 389 783 | 1 531 145 | 0,26% | Akcje |
| MARSHFIELD ASSOCIATES | $634 316 697 | 1 526 157 | 0,26% | Akcje |
| UBS Group AG | $621 815 730 | 1 496 080 | 0,26% | Akcje |
| RHUMBLINE ADVISERS | $607 608 189 | 1 461 895 | 0,25% | Akcje |
| Ensign Peak Advisors, Inc | $599 888 338 | 1 443 323 | 0,25% | Akcje |
| Qube Research & Technologies Ltd | $584 349 595 | 1 405 937 | 0,24% | Akcje |
| Caisse de depot et placement du Quebec | $566 755 977 | 1 363 607 | 0,23% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $566 576 841 | 1 363 176 | 0,23% | Akcje |
| Assenagon Asset Management S.A. | $542 834 808 | 1 306 053 | 0,22% | Akcje |
| 1832 Asset Management L.P. | $537 572 517 | 1 293 392 | 0,22% | Akcje |
| LPL Financial LLC | $531 650 741 | 1 279 144 | 0,22% | Akcje |
| Davis Selected Advisers | $529 839 298 | 1 274 650 | 0,22% | Akcje |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $528 071 215 | 1 270 532 | 0,22% | Akcje |
| WOLVERINE TRADING, LLC | $512 799 408 | 1 485 600 | 0,21% | Opcja sprzedaży |
| HSBC HOLDINGS PLC | $508 842 509 | 1 224 268 | 0,21% | Akcje |
| FIL Ltd | $462 416 638 | 1 112 568 | 0,19% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $461 418 710 | 1 110 167 | 0,19% | Akcje |
| Ninety One UK Ltd | $458 593 637 | 1 103 370 | 0,19% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $456 902 059 | 1 099 300 | 0,19% | Opcja kupna |
| Nuveen Asset Management, LLC | $449 500 757 | 888 587 | 0,18% | Akcje |
| Veritas Asset Management LLP | $448 132 682 | 1 078 201 | 0,18% | Akcje |
| NAYA CAPITAL MANAGEMENT UK LTD | $436 832 118 | 1 051 012 | 0,18% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $435 590 401 | 1 047 589 | 0,18% | Akcje |
| MACKENZIE FINANCIAL CORP | $431 689 943 | 1 038 640 | 0,18% | Akcje |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $430 280 958 | 1 035 250 | 0,18% | Akcje |
| CTC LLC | $424 566 045 | 10 215 | 0,17% | Opcja sprzedaży |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $411 538 954 | 990 157 | 0,17% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $408 705 604 | 983 340 | 0,17% | Akcje |
| JANE STREET GROUP, LLC | $402 713 051 | 968 922 | 0,17% | Akcje |
| CITADEL ADVISORS LLC | $400 319 438 | 963 163 | 0,16% | Akcje |
| CTC LLC | $395 596 634 | 9 518 | 0,16% | Opcja kupna |
| Fayez Sarofim & Co | $394 573 729 | 949 339 | 0,16% | Akcje |
| D. E. Shaw & Co., Inc. | $382 462 726 | 920 200 | 0,16% | Opcja sprzedaży |
| GOLDMAN SACHS GROUP INC | $375 355 453 | 903 100 | 0,15% | Opcja sprzedaży |
| MILLENNIUM MANAGEMENT LLC | $372 529 169 | 896 300 | 0,15% | Opcja sprzedaży |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $366 901 369 | 1 355 931 | 0,15% | Akcje |
| Allen Investment Management, LLC | $364 199 528 | 876 259 | 0,15% | Akcje |
| FIRST MANHATTAN CO. LLC. | $360 530 629 | 867 432 | 0,15% | Akcje |
| PRUDENTIAL FINANCIAL INC | $359 505 403 | 864 965 | 0,15% | Akcje |
| Longview Partners (Guernsey) LTD | $350 167 028 | 842 497 | 0,14% | Akcje |
| W1M Asset Management Ltd | $349 962 345 | 842 562 | 0,14% | Akcje |
| AVIVA PLC | $347 327 444 | 835 665 | 0,14% | Akcje |
| Point72 Asset Management, L.P. | $345 328 264 | 830 855 | 0,14% | Akcje |
| TD Asset Management Inc | $337 496 548 | 812 012 | 0,14% | Akcje |
| TORONTO DOMINION BANK | $337 017 326 | 810 859 | 0,14% | Akcje |
| PineStone Asset Management Inc. | $335 630 369 | 807 522 | 0,14% | Akcje |
| JENNISON ASSOCIATES LLC | $335 325 296 | 806 788 | 0,14% | Akcje |
| PeakShares LLC | $329 595 000 | 793 | 0,14% | Akcje |
| US BANCORP \DE\ | $328 365 156 | 790 042 | 0,13% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $325 830 242 | 761 481 | 0,13% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $320 418 726 | 770 923 | 0,13% | Akcje |
| Clearbridge Investments, LLC | $312 811 372 | 752 620 | 0,13% | Akcje |
| Robeco Institutional Asset Management B.V. | $311 375 867 | 749 166 | 0,13% | Akcje |
Insiderzy spółki 64 insiderów · 37 dyrektorzy generalni · 27 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Timothy John Noel | Chief Executive Officer, UHC | 23 czerwca 2026 A | 17 651 | 0 | 0 | $0 |
| Stephen J Hemsley | CEO, UHG | 23 czerwca 2026 A | 48 099 | 0 | 0 | $0 |
| Heather Cianfrocco | Chief Executive Officer, Optum | 18 marca 2025 A | 22 438 | 0 | 0 | $0 |
| Andrew Witty | CEO, UHG | 18 marca 2025 A | 112 162 | 0 | 0 | $0 |
| Brian R Thompson | CEO, UnitedHealthcare | 24 września 2024 A | 32 675 | 0 | 0 | $0 |
| David S Wichmann | Chief Executive Officer | 16 grudnia 2020 F | 967 872 | 0 | 0 | $0 |
| Steven H Nelson | EVP & CEO, UnitedHealthcare | 25 czerwca 2019 A | 38 502 | 0 | 0 | $0 |
| Larry C Renfro | Vice Chmn, UHG and CEO, Optum | 26 czerwca 2018 A | 153 790 | 0 | 0 | $0 |
| Gail Boudreaux | EVP & CEO, UnitedHealthcare | 23 września 2014 A | 184 732 | 0 | 0 | $0 |
| George Lawrence Mikan III | EVP UHG & CEO, Optum | 5 czerwca 2011 F | 209 279 | 0 | 0 | $0 |
| Tracy L Bahl | CEO, Uniprise | 7 listopada 2006 A | 4 230 | 0 | 0 | $0 |
| Robert J Sheehy | CEO, UnitedHealthcare | 7 listopada 2006 A | 3 009 | 0 | 0 | $0 |
| MCGUIRE WILLIAM W | Chief Executive Officer | 7 listopada 2006 A | 644 862 | 0 | 0 | $0 |
| Channing R Wheeler | CEO, Uniprise, Inc. | 28 listopada 2003 J | 8 356 | 0 | 0 | $0 |
| Wayne S Deveydt | Chief Financial Officer | 23 czerwca 2026 A | 19 779 | 0 | 0 | $0 |
| John F Rex | President & CFO | 24 czerwca 2025 A | 203 898 | 0 | 0 | $0 |
| Patrick J Erlandson | Chief Financial Officer | 2 maja 2006 A | 7 083 | 0 | 0 | $0 |
| Dirk C Mcmahon | President & COO, UHG | 19 marca 2024 A | 70 547 | 0 | 0 | $0 |
| Christopher R Zaetta | EVP & Chief Legal Officer | 23 czerwca 2026 A | 15 860 | 0 | 0 | $0 |
| Erin Mcsweeney | EVP & Chief People Officer | 23 czerwca 2026 A | 15 601 | 0 | 0 | $0 |
| Thomas E Roos | Chief Accounting Officer | 23 lutego 2026 A | 31 284 | 0 | 0 | $0 |
| Rupert M Bondy | EVP & Chief Legal Officer | 19 marca 2024 A | 9 607 | 0 | 0 | $0 |
| Marianne D Short | EVP & Chief Legal Officer | 25 lutego 2022 F | 138 315 | 0 | 0 | $0 |
| Patricia L Lewis | EVP and Chief HR Officer | 13 lutego 2022 F | 8 901 | 0 | 0 | $0 |
| Ellen D Wilson | Executive Vice President | 24 marca 2020 A | 58 387 | 0 | 0 | $0 |
| Eric S Rangen | Sr VP & Chief Acctg Officer | 24 czerwca 2015 A | 11 577 | 0 | 0 | $0 |
| Lori Sweere | EVP, Human Capital | 10 maja 2013 S | 70 661 | 0 | 0 | $0 |
| Richard N Baer | EVP & Chief Legal Officer | 28 grudnia 2012 F | 63 880 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | EVP & Chief of Medical Affairs | 5 czerwca 2012 F | 116 886 | 0 | 0 | $0 |
| William A Munsell | EVP, UnitedHealth Group | 5 czerwca 2012 F | 268 167 | 0 | 0 | $0 |
| Anthony Welters | EVP, UnitedHealth Group | 5 czerwca 2012 F | 119 909 | 0 | 0 | $0 |
| Christopher James Walsh | EVP and General Counsel | 24 maja 2011 A | 101 338 | 0 | 0 | $0 |
| Mitchell Eliot Zamoff | EVP and General Counsel | 24 maja 2011 A | 113 613 | 0 | 0 | $0 |
| Thomas L Strickland | EVP & Chief Legal Officer | 5 czerwca 2008 A | 147 182 | 0 | 0 | $0 |
| Richard H Anderson | EVP, Pres, Commercial Svcs Grp | 28 maja 2007 A | 40 606 | 0 | 0 | $0 |
| Lois E Quam | EVP & Pres, Pub & Sr Mkt Grp | 28 maja 2007 A | 13 915 | 0 | 0 | $0 |
| Forrest Gregory Burke | Acting General Counsel | 17 kwietnia 2007 A | — | 0 | 0 | $0 |
| Frederick William Mcnabb III | Dyrektor | 1 lipca 2026 A | 15 462 | 0 | 0 | $0 |
| Kristen Gil | Dyrektor | 1 lipca 2026 A | 2 617 | 0 | 0 | $0 |
| Rice Valerie Montgomery MD | Dyrektor | 1 lipca 2026 A | 7 876 | 0 | 0 | $0 |
| John H Noseworthy | Dyrektor | 1 lipca 2026 A | 7 616 | 0 | 0 | $0 |
| Charles D. Baker | Dyrektor | 1 lipca 2026 A | 2 396 | 0 | 1 | $-9 613 |
| Timothy Patrick Flynn | Dyrektor | 1 lipca 2026 A | 10 875 | 0 | 0 | $0 |
| Scott Gottlieb | Dyrektor | 1 lipca 2026 A | 659 | 0 | 0 | $0 |
| Paul R Garcia | Dyrektor | 1 lipca 2026 A | 3 906 | 0 | 0 | $0 |
| Michele J Hooper | Dyrektor | 1 kwietnia 2026 A | 41 792 | 0 | 0 | $0 |
| BURKE RICHARD T | Dyrektor | 19 maja 2022 S | 1 215 000 | 0 | 0 | $0 |
| Gail R Wilensky | Dyrektor | 1 kwietnia 2022 A | 24 690 | 0 | 0 | $0 |
| Glenn M Renwick | Dyrektor | 1 kwietnia 2021 A | 85 130 | 0 | 0 | $0 |
| BALLARD WILLIAM C JR | Dyrektor | 1 kwietnia 2020 A | 62 266 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| UnitedHealth Group Incorporated ×3 zgłoszenia | 15 stycznia 2021 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Ingenix, Inc., UnitedHealth Group Incorporated | 5 czerwca 2006 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 278 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHF · iShares Trust | 20,01% | 634 654 SH | 21 sierpnia 2026 | Dziennie |
| DJD · Invesco Exchange-Traded Fund Trust | 7,73% | 101 155 SH | 21 sierpnia 2026 | Dziennie |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 5,83% | 1 751 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 5,56% | 2 728 542 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 5,42% | 417 583 NS | 30 kwietnia 2026 | N-PORT |
| IYH · iShares Trust | 5,37% | 538 654 SH | 21 sierpnia 2026 | Dziennie |
| HRTS · Tema ETF Trust | 5,24% | 7 159 NS | 31 maja 2026 | N-PORT |
| FLAG · Global X Funds | 5,12% | 228 NS | 30 kwietnia 2026 | N-PORT |
| SCHD · SCHWAB STRATEGIC TRUST | 5,09% | 12 713 822 NS | 31 maja 2026 | N-PORT |
| RXL · ProShares Trust | 4,98% | 9 446 NS | 31 maja 2026 | N-PORT |
| DOGG · First Trust Exchange-Traded Fund IV | 4,95% | 8 762 NS | 30 kwietnia 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 4,84% | 18 062 NS | 30 kwietnia 2026 | N-PORT |
| DJIA · Global X Funds | 4,63% | 21 113 NS | 30 kwietnia 2026 | N-PORT |
| DYLG · Global X Funds | 4,61% | 732 NS | 30 kwietnia 2026 | N-PORT |
| VEGN · ETF Series Solutions | 4,22% | 17 678 NS | 30 kwietnia 2026 | N-PORT |
| GFGF · EA Series Trust | 3,98% | 3 881 NS | 29 maja 2026 | N-PORT |
| IXJ · iShares Trust | 3,79% | 428 796 SH | 21 sierpnia 2026 | Dziennie |
| EQIN · Columbia ETF Trust I | 3,65% | 27 252 NS | 30 kwietnia 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 3,45% | 12 238 NS | 31 maja 2026 | N-PORT |
| JXX · Janus Detroit Street Trust | 3,34% | 3 270 NS | 30 kwietnia 2026 | N-PORT |
| EDOW · First Trust Exchange-Traded Fund | 3,32% | 24 460 NS | 30 czerwca 2026 | N-PORT |
| DDM · ProShares Trust | 3,30% | 45 359 NS | 31 maja 2026 | N-PORT |
| PRVS · Parnassus Funds II | 3,25% | 1 978 NS | 30 czerwca 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 3,14% | 117 081 NS | 30 kwietnia 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 3,10% | 149 362 SH | 21 sierpnia 2026 | Dziennie |
| QLTY · GMO ETF Trust | 2,85% | 337 119 NS | 31 maja 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 2,72% | 735 NS | 31 maja 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 2,67% | 8 276 NS | 31 maja 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 2,67% | 4 741 NS | 31 maja 2026 | N-PORT |
| CBLS · Elevation Series Trust | 2,65% | 3 800 NS | 30 kwietnia 2026 | N-PORT |
| UDOW · ProShares Trust | 2,52% | 55 671 NS | 31 maja 2026 | N-PORT |
| TBG · EA Series Trust | 2,51% | 15 609 NS | 30 kwietnia 2026 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2,47% | 18 098 NS | 31 maja 2026 | N-PORT |
| OMAH · Tidal Trust III | 2,46% | 49 724 NS | 30 kwietnia 2026 | N-PORT |
| SNPV · DBX ETF Trust | 2,35% | 14 245 NS | 29 maja 2026 | N-PORT |
| PALC · Pacer Funds Trust | 2,35% | 14 601 NS | 30 kwietnia 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 2,25% | 2 424 NS | 31 maja 2026 | N-PORT |
| PY · Principal Exchange-Traded Funds | 2,11% | 11 168 NS | 30 czerwca 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 2,09% | 539 098 SH | 21 sierpnia 2026 | Dziennie |
| SFYF · Tidal Trust I | 2,08% | 2 389 NS | 31 maja 2026 | N-PORT |
| FLV · AMERICAN CENTURY ETF TRUST | 2,07% | 19 236 NS | 31 maja 2026 | N-PORT |
| HGRO · ETF Opportunities Trust | 2,06% | 5 413 NS | 30 kwietnia 2026 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 2,02% | 1 872 479 NS | 31 maja 2026 | N-PORT |
| GMOV · GMO ETF Trust | 2,02% | 4 839 NS | 31 maja 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 1,96% | 61 270 NS | 30 kwietnia 2026 | N-PORT |
| GVIP · Goldman Sachs ETF Trust | 1,84% | 27 590 NS | 31 maja 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 1,78% | 570 801 SH | 19 sierpnia 2026 | Dziennie |
| MEDI · Harbor ETF Trust | 1,77% | 1 315 NS | 30 kwietnia 2026 | N-PORT |
| CAPE · DoubleLine ETF Trust | 1,72% | 9 864 NS | 30 czerwca 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 1,65% | 5 130 541 SH | 19 sierpnia 2026 | Dziennie |